Patients with VHL disease have a higher incidence of renal cell carcinoma (RCC), owing to VHL gene inactivation and constitutive activation of the transcription factor hypoxia-inducible factor 2α (HIF-2α). The gene discussed is EPAS1; the disease is renal cell carcinoma.